Previously, the use of cystatin C was limited for fear that its concentration might be influenced by the extent of the cancer,8 but recent studies revealed that there is no relationship between cystatin C and tumor burden.34 Further studies are needed to assess the usefulness of cystatin C in patients with cancer. Here, CST3 is linked to neoplasm.